Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Zufferey

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Annals of the Rheumatic Diseases|October 15, 2011
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trialS Genevay, A Finckh, P Zufferey, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|December 1, 1993
[Hypertrophic osteoarthropathy disclosing hepatic and pulmonary multifocal epithelioid hemangioendothelioma]P Zufferey, M Goycochea, M Grossin, et al.
Klinische Monatsblatter Fur Augenheilkunde|February 2, 2017
Necrotising Scleritis and Peripheral Ulcerative Keratitis Associated with Rheumatoid Arthritis Treated with RituximabS Hardy, K Hashemi, M Catanese, et al.
Annales De Medecine Interne|January 1, 1995
[Lymphomas of the ocular adnexa in Gougerot-Sjögren syndrome. Apropos of 4 cases]P Chazerain, O Meyer, G Kaplan, et al.
British Journal of Clinical Pharmacology|May 19, 2007
Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years oldA Berges, S Laporte, M Epinat, et al.
Annales Francaises D'Anesthesie Et De Reanimation|September 8, 2005
[Thromboprohylaxis in orthopedic surgery and traumatology]P Mismetti, P Zufferey, G Pernod, et al.
Journal of Thrombosis and Haemostasis : JTH|May 26, 2017
Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trialsS Laporte, C Chapelle, L Bertoletti, et al.
RMD Open|May 10, 2020
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in SwitzerlandA Finckh, C Tellenbach, L Herzog, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Annals of the Rheumatic Diseases|October 15, 2011
Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trialS Genevay, A Finckh, P Zufferey, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)|December 1, 1993
[Hypertrophic osteoarthropathy disclosing hepatic and pulmonary multifocal epithelioid hemangioendothelioma]P Zufferey, M Goycochea, M Grossin, et al.
Klinische Monatsblatter Fur Augenheilkunde|February 2, 2017
Necrotising Scleritis and Peripheral Ulcerative Keratitis Associated with Rheumatoid Arthritis Treated with RituximabS Hardy, K Hashemi, M Catanese, et al.
Annales De Medecine Interne|January 1, 1995
[Lymphomas of the ocular adnexa in Gougerot-Sjögren syndrome. Apropos of 4 cases]P Chazerain, O Meyer, G Kaplan, et al.
British Journal of Clinical Pharmacology|May 19, 2007
Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years oldA Berges, S Laporte, M Epinat, et al.
Annales Francaises D'Anesthesie Et De Reanimation|September 8, 2005
[Thromboprohylaxis in orthopedic surgery and traumatology]P Mismetti, P Zufferey, G Pernod, et al.
Journal of Thrombosis and Haemostasis : JTH|May 26, 2017
Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trialsS Laporte, C Chapelle, L Bertoletti, et al.
RMD Open|May 10, 2020
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in SwitzerlandA Finckh, C Tellenbach, L Herzog, et al.
Pageof 4